Clinical Neurological Society of America (CNSA) 50th Annual Meeting

Clinical Neurological Society of America 50th Annual Meeting is organized by the Clinical Neurological Society of America (CNSA) and will be held from Jan 13 - 16, 2024 at Playa Largo Resort & Spa, Autograph Collection, Key Largo, Florida, United States of America.

Statement of Educational Need:
To improve patient care and outcomes, neurologists need a better understanding of the etiology and pathophysiology, as well as diagnosis and treatment, of primary headache syndromes; stroke syndromes; epilepsy, including those in special populations and in non-convulsive status; Rett syndrome; hypokinetic and hyperkinetic movement disorders, including Parkinson’s disease, Huntington’s disease and Tardive Dyskinesia; dementia; Alzheimer’s disease; neuromuscular diseases, including myasthenia gravis, ALS and DMD; neuro-immunological diseases, including multiple sclerosis and autoimmune encephalitis; and diabetic and inflammatory neuropathies. This educational activity is designed to improve understanding and use of current clinical practice guidelines and recent research findings in the participants’ clinical practices.

Learning Objectives:
After completing this activity, the participant should be better able to:
• Identify and differentiate primary headache syndromes by current classification.
• Explain new medications and strategies for treating headache and migraine disease.
• Describe the etiologies, treatment and outcomes of pediatric migraine.
• Describe various stroke syndromes and strategies for acute stroke management.
• Outline strategies for diagnosing and managing patients in non-convulsive status epilepticus.
• Describe the etiologies, treatment and outcomes of special patient populations with epilepsy.
• Identify the signs, symptoms and treatments for Rett syndrome.
• Discuss strategies for diagnosis and management of vertigo and dizziness.
• Explain new approaches to patient care related to tele-neurology, digital health and artificial intelligence.
• Describe clinical updates and new treatments related to hypokinetic (i.e. Parkinson’s disease) and hyperkinetic movement disorders.
• Explain the latest literature relative to the prevention of cognitive decline and brain health.
• Discuss strategies for achieving accurate dementia diagnoses.
• Explain new medications and strategies for treating Alzheimer’s disease.
• Describe advances in the diagnosis and treatment of neuromuscular diseases, including myasthenia gravis, ALS and DMD.
• Describe advances in the diagnosis and treatment of neuroimmunological diseases, including multiple sclerosis subtypes and autoimmune encephalitis.
• Explain updated clinical guidelines related to the management of diabetic and inflammatory neuropathies.